Asthma, a Disease Due to a Lack of Bacterial Infections in Childhood.

NCT00200928 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2006-04-04

No results posted yet for this study

Summary

The degree of TH1-skewing by mycobacteria is controlles by NRAMP1 gene polymorphisms and related to the degree of inhibition of TH2-mediated disease.

Conditions

Interventions

BIOLOGICAL

BCG

Sponsors & Collaborators

  • The Netherlands Asthma Foundation

    lead OTHER

Principal Investigators

  • Maarten O Hoekstra, MD PhD · Wilhelmina Children's Hospital Utrecht (UMCU)

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-01-31
Completion
2005-07-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00200928 on ClinicalTrials.gov